Direct Inhibition of Hypoxia-Inducible Transcription Factor Complex with Designed Dimeric Epidithiodiketopiperazine
Authors:
- Hui WangHWHui Wang
- Lajos Z. SzabóLSLajos Z. Szabó
- Nathan W. PolaskeNPNathan W. Polaske
- Laura K. HencheyLHLaura K. Henchey
- Ramin DubeyRDRamin Dubey
- Swati KushalSKSwati Kushal
- Csaba F. LászlóCLCsaba F. László
- Joshua MakhoulJMJoshua Makhoul
- Zuohe SongZSZuohe Song
- Emmanuelle J. MeuilletEMEmmanuelle J. Meuillet
- Bogdan Z. OlenyukBOBogdan Z. Olenyuk
- 17 June 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (50) , 18078-18088
Abstract
Selective blockade of hypoxia-inducible gene expression by designed small molecules would prove valuable in suppressing tumor angiogenesis, metastasis and altered energy metabolism. We report the design, synthesis, and biological evaluation of a dimeric epidithiodiketopiperazine (ETP) small molecule transcriptional antagonist targeting the interaction of the p300/CBP coactivator with the transcription factor HIF-1α. Our results indicate that disrupting this interaction results in rapid downregulation of hypoxia-inducible genes critical for cancer progression. The observed effects are compound-specific and dose-dependent. Controlling gene expression with designed small molecules targeting the transcription factor-coactivator interface may represent a new approach for arresting tumor growth.Keywords
This publication has 47 references indexed in Scilit:
- Molecular Solids from Symmetrical Bis(piperazine-2,5-diones) with Open- and Closed-Monomer ConformationsCrystal Growth & Design, 2009
- Modulating Hypoxia-Inducible Transcription by Disrupting the HIF-1–DNA InterfaceACS Chemical Biology, 2007
- Hypoxia: A key regulator of angiogenesis in cancerCancer and Metastasis Reviews, 2007
- Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamideProceedings of the National Academy of Sciences, 2007
- VEGF-A and the Induction of Pathological AngiogenesisAnnual Review of Pathology: Mechanisms of Disease, 2007
- Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stressBlood, 2006
- Programmable Oligomers for Minor Groove DNA RecognitionJournal of the American Chemical Society, 2006
- The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensingBiochemical and Biophysical Research Communications, 2005
- A General Framework for Development and Data Analysis of Competitive High-Throughput Screens for Small-Molecule Inhibitors of Protein−Protein Interactions by Fluorescence PolarizationBiochemistry, 2004
- The Hallmarks of CancerCell, 2000